Learn more

INHIBRX LP

Overview
  • Total Patents
    59
  • GoodIP Patent Rank
    33,217
  • Filing trend
    ⇩ 75.0%
About

INHIBRX LP has a total of 59 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are PIERIS PROTEOLAB AG, ARGEN-X N V and DAVIES JULIAN.

Patent filings per year

Chart showing INHIBRX LPs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Deveraux Quinn 48
#2 Eckelman Brendan P 40
#3 Timmer John C 40
#4 Razai Amir S 16
#5 Hussain Abrahim 16
#6 Jones Kyle S 16
#7 Willis Katelyn M 11
#8 Nguy Peter L 11
#9 Eckelman Brendan 8
#10 Timmer John 8

Latest patents

Publication Filing date Title
CN107922491A The fusion protein of multivalence and polyspecific combination DR5
EP3247407A1 Non-immunogenic single domain antibodies
BR112017008525A2 isolated fusion protein, and methods for treating or alleviating a symptom of a disease or disorder, for treating or alleviating an inflammation or symptom of an inflammatory disease or disorder, and for reducing the risk of infection in an individual.
US2015104410A1 Serpin fusion polypeptides and methods of use thereof